The Centers for Medicare & Medicaid Services (CMS) announced in late-December that they have approved six quality measures that were developed by ACMT. These are the first-ever medical toxicology quality measures approved by CMS, and are now among hundreds of measures that physicians can report to CMS as part of their Merit-Based Incentive Payment System (MIPS) program.
CMS also certified ACMT’s Toxicology Investigators Consortium (ToxIC) Registry as a Qualified Clinical Data Registry (QCDR).
The ToxIC registry will go live with the ToxIC QCDR on February 1, a metrics instrument which seeks to demonstrate systematically the benefits to patients cared for by medical toxicologists. Quality metrics, long established in most specialities under directives from the Centers for Medicare and Medicaid (CMS), have now come to medical toxicology. These metrics were developed by an ACMT tasks force in conjunction with the membership at large and have been approved by CMS. They will be incorporated into the ToxIC Registry.
Click for more information and the registration form for the QCDR.